This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Canadian Blood Services. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2013
Title: Alan H Lazarus: Innovator in Autoimmune Disease Treatment
Introduction
Alan H Lazarus is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of three patents to his name, Lazarus is recognized for his innovative approaches to complex medical challenges.
Latest Patents
Lazarus's latest patents include a groundbreaking method for treating autoimmune diseases and compositions therefor. This method involves a cell-based therapy aimed at stimulating leukocytes and/or dendritic cells to interrupt autoimmunity in a host. The technique utilizes a Fcγ receptor-specific complex or a complex that facilitates the co-crosslinking of Fcγ-chains to treat leukocytes and/or dendritic cells. Upon reintroducing the pre-treated biological sample to the patient, the dendritic cells elicit an autoimmune interruption response in vivo. Another notable patent focuses on methods of inhibiting platelet anti-HLA alloimmune antibody responses using a soluble 18 KDa CD40L. This invention relates to inhibiting an in vivo alloimmune response through the use of a soluble recombinant human CD40L protein.
Career Highlights
Lazarus is currently affiliated with Canadian Blood Services, where he applies his expertise to advance medical research and treatment methodologies. His work has been instrumental in developing innovative solutions for patients suffering from autoimmune conditions.
Collaborations
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile